Skip to main content
Log in

Contrast-enhanced ultrasound in pediatric echocardiography

  • Contrast-enhanced ultrasound (CEUS) in children
  • Published:
Pediatric Radiology Aims and scope Submit manuscript

Abstract

The safety and benefits of cardiac contrast-enhanced ultrasound (CEUS) have been demonstrated in children and adolescents for a variety of clinical indications, including congenital heart disease. Cardiac CEUS is performed with US and the intravenous administration of ultrasound contrast agents (UCAs). It improves transthoracic echocardiography, which can be challenging in children and adults with acoustic window limitations (e.g., from obesity) and alterations in chest wall and cardiac geometry (e.g., from prior surgical procedures). Cardiac CEUS is also used to evaluate ischemia in the follow-up of congenital and acquired heart disease. In 2019, the United States Food and Drug Administration (FDA) approved a UCA for pediatric echocardiography. This article focuses on the clinical applications of UCAs in pediatric and adult echocardiography, outlining its diagnostic value, safety and potential for future applications.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9

Similar content being viewed by others

References

  1. Abdelmoneim SS, Bernier M, Scott CG et al (2010) Safety of contrast agent use during stress echocardiography in patients with elevated right ventricular systolic pressure: a cohort study. Circ Cardiovasc Imaging 3:240–248

    Article  Google Scholar 

  2. Khawaja OA, Shaikh KA, Al-Mallah MH (2010) Meta-analysis of adverse cardiovascular events associated with echocardiographic contrast agents. Am J Cardiol 106:742–747

    Article  Google Scholar 

  3. Main ML, Goldman JH, Grayburn PA (2007) Thinking outside the "box" — the ultrasound contrast controversy. J Am Coll Cardiol 50:2434–2437

    Article  Google Scholar 

  4. Calliada F, Campani R, Bottinelli O et al (1998) Ultrasound contrast agents: basic principles. Eur J Radiol 27:S157–S160

    Article  Google Scholar 

  5. Gramiak R, Shah PM (1968) Echocardiography of the aortic root. Investig Radiol 3:356–366

    Article  CAS  Google Scholar 

  6. Bracco Diagnostics (2021) Lumason. https://imaging.bracco.com/sites/braccoimaging.com/files/technica_sheet_pdf/us-en-2017-01-04-spc-lumason.pdf. Accessed 19 May 2021

  7. GE Healthcare (2016) Optison. http://www3.gehealthcare.com/~/media/documents/MarketoPDFsnogating/OPT-1H-OSLO_Optison_BK. Accessed 19 May 2021

  8. United States Food and Drug Administration (2011) Highlights of prescribing information: Definity. https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021064s011lbl.pdf. Accessed 19 May 2021

  9. Muskula PR, Main ML (2017) Safety with echocardiographic contrast agents. Circ Cardiovasc Imaging 10:e005459

    Article  Google Scholar 

  10. Porter TR, Mulvagh SL, Abdelmoneim SS et al (2018) Clinical applications of ultrasonic enhancing agents in echocardiography: 2018 American Society of Echocardiography guidelines update. J Am Soc Echocardiogr 31:241–274

    Article  Google Scholar 

  11. Porter TR, Abdelmoneim S, Belcik JT et al (2014) Guidelines for the cardiac sonographer in the performance of contrast echocardiography: a focused update from the American Society of Echocardiography. J Am Soc Echocardiogr 27:797–810

    Article  Google Scholar 

  12. Rafter P, Phillips P, Vannan MA (2004) Imaging technologies and techniques. Cardiol Clin 22:181–197

    Article  Google Scholar 

  13. National Institutes of Health (2021) Study to determine dosage of Optison in pediatric patients. ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03740997. Accessed 19 May 2021

  14. McMahon CJ, Ayres NA, Bezold LI et al (2005) Safety and efficacy of intravenous contrast imaging in pediatric echocardiography. Pediatr Cardiol 26:413–417

    Article  CAS  Google Scholar 

  15. Zilberman MV, Witt SA, Kimball TR (2003) Is there a role for intravenous transpulmonary contrast imaging in pediatric stress echocardiography? J Am Soc Echocardiogr 16:9–14

    Article  Google Scholar 

  16. Kutty S, Olson J, Danford CJ et al (2012) Ultrasound contrast and real-time perfusion in conjunction with supine bicycle stress echocardiography for comprehensive evaluation of surgically corrected congenital heart disease. Eur Heart J Cardiovasc Imaging 13:500–509

    Article  Google Scholar 

  17. Kutty S, Xiao Y, Olson J et al (2016) Safety and efficacy of cardiac ultrasound contrast in children and adolescents for resting and stress echocardiography. J Am Soc Echocardiogr 29:655–662

    Article  Google Scholar 

  18. Hoffmann R, Barletta G, von Bardeleben S et al (2014) Analysis of left ventricular volumes and function: a multicenter comparison of cardiac magnetic resonance imaging, cine ventriculography, and unenhanced and contrast-enhanced two-dimensional and three-dimensional echocardiography. J Am Soc Echocardiogr 27:292–301

    Article  Google Scholar 

  19. Goldberg AB, Lama von Buchwald C, Kalra DK, Rao AK (2019) An unusual cardiac metastasis: right atrial chondrosarcoma diagnosed with multimodality cardiac imaging. CASE 3:162–166

    Article  Google Scholar 

  20. Bisoyi S, Dash AK, Nayak D et al (2016) Left ventricular pseudoaneurysm versus aneurysm a diagnosis dilemma. Ann Card Anaesth 19:169–172

    Article  Google Scholar 

  21. Main ML, Hibberd MG, Ryan A et al (2014) Acute mortality in critically ill patients undergoing echocardiography with or without an ultrasound contrast agent. JACC Cardiovasc Imaging 7:40–48

    Article  Google Scholar 

  22. Wever-Pinzon O, Suma V, Ahuja A et al (2012) Safety of echocardiographic contrast in hospitalized patients with pulmonary hypertension: a multi-center study. Eur Heart J Cardiovasc Imaging 13:857–862

    Article  Google Scholar 

  23. Ntoulia A, Anupindi SA, Back SJ et al (2021) Contrast-enhanced ultrasound: a comprehensive review of safety in children. Pediatr Radiol. In press

  24. Kutty S, Wu J, Hammel JM et al (2012) Microbubble mediated thrombus dissolution with diagnostic ultrasound for the treatment of chronic venous thrombi. PLoS One 7:e51453

    Article  CAS  Google Scholar 

  25. Kutty S, Liu N, Zhou J et al (2017) Ultrasound induced microbubble cavitation for the treatment of catheterization induced vasospasm. JACC Basic Transl Sci 2:748–756

    Article  Google Scholar 

  26. Mathias W Jr, Arrieta SR, Tavares GMP et al (2019) Successful recanalization of thrombotic occlusion in pulmonary artery stent using sonothrombolysis. CASE 3:14–17

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Shelby Kutty.

Ethics declarations

Conflicts of interest

Dr. Feinstein is a speaker for GE Healthcare and Bracco Imaging. Dr. Kutty is a consultant for GE Healthcare.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kutty, S., Biko, D.M., Goldberg, A.B. et al. Contrast-enhanced ultrasound in pediatric echocardiography. Pediatr Radiol 51, 2408–2417 (2021). https://doi.org/10.1007/s00247-021-05119-3

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00247-021-05119-3

Keywords

Navigation